Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Z. Chen
Observed names:
Zai Zhao Chen,
Zailing Chen,
Zi-Qing Chen
Institutions:
Jiangxi University of Traditional Chinese Medicine,
Yunnan Provincial Department of Education,
Yunnan Land and Resources Vocational College
Observed institutions:
Jiangxi University of Traditional Chinese Medicine,
Zhejiang Cancer Hospital,
Yunnan Provincial Department of Education,
Yunnan Land and Resources Vocational College,
Taipei Medical University
ORCID:
0009-0006-9855-7916
Observed ORCID:
0009-0006-9855-7916
OpenAlex ID:
A5043202964
719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer
2024
·
E.K. Lee
, O. Yeku
, et al.
·
Annals of Oncology
·
20
PDF
MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT
2024
·
Yen-Nien Liu
, Wei-Yu Chen
, et al.
·
Science Signaling
·
11
Effects of acupuncture on improving sleep quality and the risk of emotional maladjustment of breast cancer patients: a systematic review and meta-analysis
2025
·
Yi Yang
, Hong Wang
, et al.
·
Frontiers in Oncology
·
5
A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer
2014
·
Z. Chen
, S. Xu
, et al.
·
Clinical & Translational Oncology
·
2
PDF
Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China
2020
·
X. Xie
, Y. Shen
, et al.
·
Gynecologic Oncology
·
1
Enrichment and source apportionment of potentially toxic elements in human scalp hair from the “Tin Capital” Gejiu and surrounding cities, China
2025
·
Shuran Yang
, Qianrui Huang
, et al.
·
Environmental Geochemistry and Health
PDF
MO44-2 Leukemia inhibitory factor signaling drives immunosuppression and neuroendocrine differentiation in prostate cancer
2024
·
Y. Liu
, M. Liu
, et al.
·
Annals of Oncology
PDF
What influences the long-term survival of advanced high-grade serous ovarian cancer?
2020
·
X. Xie
, L. Jin
, et al.
·
Gynecologic Oncology
Secondary cytoreduction in relapsed serous ovarian cancer: Who really benefits?
2020
·
X. Xie
, S. Tang
, et al.
·
Gynecologic Oncology
Potential Metabolites With Diagnostic Value in Plasma for Angioimmunoblastic T‐cell Lymphoma by Lc‐ms Based Untargeted Metabonomics Study
2019
·
H. Yang
, T. Lei
, et al.
·
Hematological Oncology
Everolimus-based therapy versus conventional therapy for refractory breast cancer patients with PI3K/AKT/mTOR mutations
2018
·
Z. Chen
, Y. Zheng
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
11
Citation count:
39
H-index:
3
I10-index:
2
Year
Topic
Type